Full Name
Sohail Chaudhry
Job Title
Chief Technology Officer
Company
Food and Drug Administration
Speaker Bio
Mohammed Sohail Chaudhry is a strategic leader with progressive and vibrant ideology of transformative change in the delivery of technology and information management processes with a proven record of saving millions in information technology (IT) expenses by leveraging secure innovation and business transformation. Currently serving as the Chief Technology Officer (CTO) at the United States Food and Drug Administration (FDA) where he is responsible for standardization and modernization of IT by leading development of enterprise solutions while enabling the Office of Information Management and Technology (OIMT) to align and integrate with the strategic business objectives of the agency.
Prior to that, Mr. Chaudhry served as the Chief Technology Architect (CTA) and as the Director of the Division of Infrastructure Operations (DIO) leading the implementation, operations and maintenance of enterprise IT. Additionally, he has led the Risk and Compliance Division of OIMT at the FDA as the Deputy Chief Information Security Officer (D-CISO) and as a Senior Technical Advisor, where he established the foundation for FDA’s cloud, mobile technology and multiple security initiatives for the development and execution of processes that enable the FDA to efficiently leverage emerging solutions. He systematically developed and implemented enterprise technology programs, which reduced disruptions to business systems by nearly 80% and modernized the operational functionality and stability across FDA’s IT enterprise.
Prior to that, Mr. Chaudhry served as the Chief Technology Architect (CTA) and as the Director of the Division of Infrastructure Operations (DIO) leading the implementation, operations and maintenance of enterprise IT. Additionally, he has led the Risk and Compliance Division of OIMT at the FDA as the Deputy Chief Information Security Officer (D-CISO) and as a Senior Technical Advisor, where he established the foundation for FDA’s cloud, mobile technology and multiple security initiatives for the development and execution of processes that enable the FDA to efficiently leverage emerging solutions. He systematically developed and implemented enterprise technology programs, which reduced disruptions to business systems by nearly 80% and modernized the operational functionality and stability across FDA’s IT enterprise.
Speaking At